Alzheimer's-Related Agitation Clinical Trials

Experiencing Agitation with Alzheimer’s Disease?

Explore Alzheimer’s-Related Agitation Clinical Trials Investigating Novel Treatment Options!

Alzheimer’s disease is the most common form of dementia. It is a neurodegenerative disorder that leads to morbidity and eventual mortality. Agitation in Alzheimer’s patients, aggression, hallucination, and delusions are estimated to affect 90% of people with Alzheimer’s disease, with an increasing prevalence as the disease progresses.

At present, there are no FDA-approved treatments for symptoms of agitation in Alzheimer’s patients. As a result, people with symptoms of agitation in Alzheimer’s disease are often treated with off-label antipsychotics, which result in a functional decline with Alzheimer’s disease. Revive Research Institute is conducting paid Alzheimer’s-Related Agitation Clinical Trials for agitation symptoms and investigating potential treatment options.

You may qualify for the paid Agitation Associated with Alzheimer’s Dementia Clinical Study if you:

• Are between 50 to 90 years of age
• Have been diagnosed with Alzheimer’s disease
• Have moderate to severe agitation for at least 2 weeks

*Additional criteria may apply

*Take part in paid Alzheimer’s-Related Agitation Clinical Trials at no cost to you or your private medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the Alzheimer’s-Related Agitation Clinical Trials or would like more information, please fill out the form so we can determine if you qualify for the study and can contact you. Note that this is an entirely voluntary decision.

Get Started: What to Expect?

If you or someone you know is suffering from Alzheimer’s disease and would like to participate in our paid Alzheimer’s-Related Agitation Clinical Trials, please reach out to us by filling out the form above. One of our study team representatives will call you to see if you are a fit for this study as part of our screening process.

If you fulfill the initial screening criteria, you may be asked to visit the Agitation Associated with Alzheimer’s Dementia Clinical Study site. Our research team will discuss in detail with you the clinical during the Informed Consent process. After that, you will undergo a series of health-related questions and tests to confirm your eligibility as a participant.

Once you receive confirmation of eligibility, you will formally be a part of the Alzheimer’s-Related Agitation Clinical Trials. You will receive all the information about the research study you might enroll in during the ICF process. We encourage you to ask as many questions as you would like before deciding to participate.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.